Albumedix and Heartseed announce Recombumin as a critical excipient in the manufacture of HS-001
14 Mar 2023 //
PR NEWSWIRE
Sartorius completes acquisition of Albumedix
30 Sep 2022 //
PRESS RELEASE
Sartorius to acquire Albumedix, for £415 million
10 Aug 2022 //
PHARMABIZ
Albumedix, Valneva Expand Collaboration to Include Inactivated COVID-19 Vaccine
14 Apr 2022 //
PRNEWSWIRE